Kodiak Sciences (STU:K27) Construction In Progress : €0.00 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Kodiak Sciences Construction In Progress?

Kodiak Sciences's quarterly construction in progress increased from Sep. 2023 (€0.00 Mil) to Dec. 2023 (€4.01 Mil) but then declined from Dec. 2023 (€4.01 Mil) to Mar. 2024 (€0.00 Mil).

Kodiak Sciences's annual construction in progress declined from Dec. 2021 (€33.46 Mil) to Dec. 2022 (€4.27 Mil) and declined from Dec. 2022 (€4.27 Mil) to Dec. 2023 (€4.01 Mil).

Kodiak Sciences Construction In Progress Historical Data

The historical data trend for Kodiak Sciences's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kodiak Sciences Construction In Progress Chart

Kodiak Sciences Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

1.83

33.46

4.27

4.01

Kodiak Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															-	-	-	4.01	-

Kodiak Sciences Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Kodiak Sciences (STU:K27) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kodiak Sciences Inc (STU:K27) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

KOD:USA K27:Germany

Address

1200 Page Mill Road, Palo Alto, CA, USA, 94304

Website

https://www.kodiak.com

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.

Kodiak Sciences (STU:K27) Headlines

No Headlines